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Abstract: Influenza viruses of avian origin continue to pose pandemic threats to human 
health. Some of the H5N1 and H9N2 virus subtypes induce markedly elevated cytokine 
levels when compared with the seasonal H1N1 virus. We previously showed that H5N1/97 
hyperinduces tumor necrosis factor (TNF)-alpha through p38 mitogen activated protein 
kinase (MAPK). However, the detailed mechanisms of p38MAPK activation and TNF-alpha 
hyperinduction following influenza virus infections are not known. Negative feedback 
regulations of cytokine expression play important roles in avoiding overwhelming 
production of proinflammatory cytokines. Here we hypothesize that protein phosphatases 
are involved in the regulation of cytokine expressions during influenza virus infection. We 
investigated the roles of protein phosphatases including MAPK phosphatase-1 (MKP-1) and 
protein phosphatase type 2A (PP2A) in modulating p38MAPK activation and downstream 
TNF-alpha expressions in primary human monocyte-derived macrophages (PBMac) 
infected with H9N2/G1 or H1N1 influenza virus. We demonstrate that H9N2/G1 virus 
activated p38MAPK and hyperinduced TNF-alpha production in PBMac when compared 
with H1N1 virus. H9N2/G1 induced PP2A activity in PBMac and, with the treatment of a 
PP2A inhibitor, p38MAPK phosphorylation and TNF-alpha production were further 
increased in the virus-infected macrophages. However, H9N2/G1 did not induce the 
expression of PP2A indicating that the activation of PP2A is not mediated by p38MAPK in 
virus-infected PBMac. On the other hand, PP2A may not be the targets of H9N2/G1 in the 
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upstream of p38MAPK signaling pathways since H1N1 also induced PP2A activation  
in primary macrophages. Our results may provide new insights into the control of  
cytokine dysregulation. 
Keywords: protein phosphatase 2A; tumor necrosis factor-alpha; p38 mitogen activated 
protein kinase; influenza virus 
 
1. Introduction 
Influenza viruses continue to pose pandemic and epidemic threats to the public. Infection of humans 
with the highly pathogenic avian influenza H5N1 virus is associated with mortality in excess of 60% [1]. 
Fatal outcomes of H5N1 virus infections are associated with high viral load and hypercytokinemia [2]. 
Avian H9N2 Quail/HK/G1/97 (H9N2/G1) virus is one of the precursor viruses of the highly pathogenic 
H5N1/97 virus [3]. With the prevalent circulations of H9N2 virus in quail in southern China [4] and 
several zoonotic transmission cases [5–8], H9N2 virus may evolve into a human-adapted avian 
influenza virus with pandemic potential [9]. We have previously demonstrated that H5N1/97 virus 
hyperinduces tumor necrosis factor (TNF)-alpha expression in primary monocyte-derived macrophages 
(PBMac), which is mediated by p38 mitogen activated protein kinase (MAPK) [10]. Recent reports, 
including ours, showed that H9N2/G1 virus also hyperinduces proinflammatory cytokines and 
chemokines comparable to H5N1/97 [11,12]. However, the roles of p38MAPK and other MAPK family 
members in H9N2/G1-induced TNF-alpha expression in PBMac are still unclear. 
MAPK signaling pathways play key roles in the induction of inflammatory reactions including 
production of proinflammatory cytokines such as TNF-alpha, IL-1β and IL-6. Since the uncontrolled 
cytokine productions can lead to detrimental effects to the host, activation of MAPK also induces the 
negative feedback mechanisms to regulate the immune responses. Hence, MAPK and phosphatases are 
key players in the regulation of pro- and anti-inflammatory responses in the host. Reports have shown 
that MAPK phosphatase-1 (MKP-1) and protein phosphatase type 2A (PP2A) are two well-known 
negative regulators of p38MAPK. MKP-1 deficient mice are susceptible to septic shock [13,14].  
In response to lipopolysaccharide, macrophages from MKP-1 deficient mice show prolong activation of 
p38MAPK and enhanced production of TNF-alpha and IL-6 [15]. PP2A constitutes a large family of 
Ser⁄Thr phosphatases, which are involved in diverse cellular functions [16]. PP2A suppresses the 
activations of p38MAPK and the upstream kinases of MAPK signaling pathways [17–19]. It has been 
shown that viruses develop various strategies to target PP2A in order to counteract host antiviral 
responses [20]. However, the roles of MKP-1 and PP2A in cytokine regulation during influenza virus 
infections have not been reported. Here, we show that H9N2/G1 virus activated p38MAPK and 
hyperinduced production of TNF-alpha in PBMac when compared with H1N1 virus. Moreover, the 
phosphorylation levels of p38MAPK and subsequent TNF-alpha expression in H9N2/G1-infected 
macrophages were further increased by the treatment of a selective inhibitor of PP2A, okadaic acid 
(OA). Interestingly, OA also increased the levels of p38MAPK phosphorylation and TNF-alpha mRNA 
in H1N1-infected macrophages. These results provide insights into the complex mechanisms of 
MAPK-mediated cytokine production during influenza virus infections. 
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2. Results and Discussion 
2.1. H9N2/G1 Hyperinduced TNF-alpha Expression through the Activation of p38MAPK in Primary 
Human Blood Macrophages 
Our previous reports demonstrate that avian influenza viruses including H5N1 and H9N2/G1 induce 
high levels of TNF-alpha production in macrophages in contrast to those cells infected with human 
influenza virus subtypes H3N2 and H1N1 [10,11]. In addition, H5N1-induced TNF-alpha expression is, 
in large part, mediated by the activation of p38MAPK [10]. To investigate the mechanisms of 
p38MAPK-mediated hyperinduction of TNF-alpha, we examined the kinetics of p38MAPK activation 
and TNF-alpha expression in PBMac infected with H9N2/G1 or H1N1 virus. PBMac were mock-treated 
or infected with H9N2/G1 or H1N1 at a multiplicity of infection (m.o.i.) of 2. At indicated time points, 
total RNA of treated cells were harvested for examining the levels of TNF-alpha mRNA by using 
TaqMan Gene Expression Assay as previously reported [10]. The levels of TNF-alpha production in 
culture supernatants were measured by using enzyme-linked immunosorbent assay (ELISA). Like 
H5N1 viruses, H9N2/G1 significantly increased TNF-alpha levels when compared with H1N1-infected 
PBMac (Figure 1A,B). We then examined the phosphorylation levels of p38MAPK, ERK1/2, and JNK 
in the H9N2/G1- or H1N1-infected PBMac by using Western blot analysis. H9N2/G1 activated 
p38MAPK and ERK1/2, but not JNK, from 1 to 2 h post-infection (h.p.i.) (Figure 1C, lanes 9–12) when 
compared with the mock-treated control (Figure 1C, lanes 1–4) or H1N1-infected PBMac (Figure 1C, 
lanes 5–8). Moreover, the levels of p38MAPK phosphorylations induced by H9N2/G1 were higher than 
those of ERK1/2 (Figure 1C, lane 11).  
Furthermore, we examined the roles of p38MAPK in the TNF-alpha induction by using a specific 
p38MAPK inhibitor, SB203580. PBMac were treated with SB203580 at the indicated doses for 30 min, 
and then infected with H9N2/G1 virus. The levels of TNF-alpha mRNA and protein were measured at  
3 h.p.i. and 16 h.p.i., respectively. Notably, the levels of TNF-alpha mRNA and protein in 
H9N2/G1-infected PBMac were significantly suppressed by SB203580 and in a dose dependent manner 
(Figure 1D,E). The suppressive effect of SB203580 on the activities of p38MAPK was shown in 
supplementary figure (Figure S1A) and SB203580 did not show cytotoxic effects on the 
H9N2/G1-infected PBMac (Figure S1B). By examining the levels of influenza virus nucleoprotein using 
Western blot, we show that SB203580 did not affect the expression level of the viral protein suggesting 
that SB203580 did not interfere with H9N2/G1 infection (Figure S1C). To summarize, H9N2/G1 
induced a significantly higher level of TNF-alpha when compared with the seasonal H1N1 and the 
hyperinduction was mediated through p38MAPK.  
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Figure 1. H9N2/G1 hyperinduces tumor necrosis factor (TNF)-alpha expression via the 
activation of p38MAPK in primary human blood macrophages. Primary human 
monocyte-derived macrophages (PBMac) were mock-treated or infected with H9N2/G1 or 
H1N1 at a multiplicity of infection (m.o.i.) of 2. Total RNA, culture supernatant or cell 
lysates were collected at the indicated time points. (A) Quantitative RT-PCR analysis of 
TNF-alpha mRNA by using TaqMan Gene Expression Assay in H9N2/G1 or H1N1-infected 
PBMac; (B) TNF-alpha levels in cell culture supernatant of the H9N2/G1 or H1N1-infected 
PBMac as determined by ELISA; (C) Western blot analysis of the phosphorylation of 
MAPKs. The phosphorylation levels of p38MAPK, ERK1/2 and JNK were determined by 
using specific antibodies. Actin was used as a loading control. Protein band intensities were 
determined by using Bio-Rad Quantity One imaging software. The band intensities of the 
phosphorylated proteins were normalized to the corresponding actin intensities. The 
normalized values are presented in the graphs. Representative figure of experiments from 
five independent blood donors is shown; (D & E) PBMac were pre-treated with the indicated 
doses of p38MAPK inhibitor (SB203580) for 30 min prior to H9N2/G1 infections; (D) The 
levels of TNF-alpha mRNA at 3 h.p.i. were examined by TaqMan Gene Expression Assay; 
(E) TNF-alpha protein in culture supernatants at 16 h.p.i. were measured by ELISA. The 
relative TNF-alpha mRNA and protein levels in the SB203580-treated cells compared to the 
mock-treated cells (DMSO) are shown. * p < 0.05; h.p.i., hour post infection; ELISA, 
enzyme-linked immunosorbent assay; DMSO, dimethylsulphoxide. 
 
(A) (B) 
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2.2. H9N2/G1 Virus Did Not Alter the Cellular Protein Levels of MKP-1 and PP2A Catalytic Subunit 
To investigate the involvement of the negative regulators of p38MAPK upon influenza virus 
infections, we measured the expressions of MKP-1 and PP2A catalytic subunit in H9N2/G1- or 
H1N1-infected PBMac at the indicated time points. We show that H9N2/G1 and H1N1 did not induce 
the expression of MKP-1 from 0.5 to 4 h.p.i. when compared with the mock-treated cells (Figure 2A). 
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Previous reports have shown that HIV or coronavirus induces MKP-1 expression which in turn to 
modulate the excessive production of cytokines in virus-infected cells [21,22]. However, our results 
show that MKP-1 expression was not enhanced by the influenza viruses. Similar to MKP-1, PP2A 
expressions were not modulated by H9N2/G1- or H1N1-infected PBMac (Figure 2B). These results 
suggest that the regulation of MKP-1 and PP2A expressions are dispensable to the p38MAPK activity in 
influenza virus-infected PBMac. 
Figure 2. Expression levels of MKP-1 and PP2A catalytic subunit were not affected by 
H9N2/G1 and H1N1 infections. Primary human monocyte-derived macrophages (PBMac) 
were mock-treated, and infected with H1N1 or H9N2/G1 viruses. Total cell lysates were 
harvested at the indicated time points after infections and the expression levels of MKP-1 
(A) and PP2A catalytic subunit (PP2Ac) (B) were examined by Western blot analysis. 
Representative figure of experiments from five independent blood donors is shown. Actin 
was used as a loading control. Graphical presentation of the expressions of MKP-1 and 
PP2A were shown in the lower panel of (A) and (B). The densities of the protein bands were 
determined by using Bio-Rad Quantity One imaging software. The MKP-1 (A) and PP2Ac 
(B) levels were normalized with the corresponding actin levels. The values in the graphs 
represent the normalized values. h.p.i., hour post infection. 
0.5 1 2 4 h.p.i.  
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2.3. H9N2/G1 Induced PP2A Activity in Primary Human Blood Macrophages 
Whether the activity of PP2A was modulated during H9N2/G1 infection, we examined the PP2A 
activity in the H9N2/G1-infected cells by using the PP2A Phosphatase Assay Kit (Millipore, Billerica, 
MA, USA) (Figure 3A). Surprisingly, despite H9N2/G1 induced high level of p38MAPK phosphorylation, 
the PP2A activity was increased when compared with the mock-treated cells. The activity of  
PP2A induced by H9N2/G1 was abrogated by okadaic acid (OA), a selective PP2A inhibitor, at 25 nM  
(Figure 3A). OA is a reversible, non-competitive inhibitor of the serine/theorine protein phosphatases 
PP1 and PP2A [23]. However, OA inhibits PP2A activities at 1–2 nM whereas it inhibits PP1 above 1 
μM in tissue extracts [24]. Meanwhile, cytotoxicity of OA in PBMac was examined (Figure S2). PBMac 
were treated with OA at the indicated concentrations and the survivals of treated cells were measured by 
MTT assay after incubating for 4 to 24 h. Results show that OA did not induce cell death in PBMac. 
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Figure 3. Involvement of PP2A in modulating the activation of p38MAPK phosphorylation 
and TNF-alpha hyperinduction in H9N2/G1-infected primary human blood macrophages. 
(A) Primary human monocyte-derived macrophages (PBMac) were mock-treated or treated 
with 25 nM okadaic acid (OA) for 30 min prior to H9N2/G1 virus infection. At 2 h.p.i., the 
PP2A activity was quantified by using the PP2A Phosphatase Assay Kit (Millipore);  
(B) Left panel: Effects of OA on the p38MAPK phosphorylation. PBMac were treated with 
the indicated doses of OA for 30 min prior to H9N2/G1 infection. At 2 h.p.i., cell lysates 
were collected and the phosphorylation levels of p38MAPK were determined by using 
Western blot analysis. Representative figure of experiments from five independent blood 
donors is shown; Right panel: graphical presentation of the Western blot analysis. The 
densities of the protein bands were determined by using Bio-Rad Quantity One imaging 
software. Actin was used as a loading control. The band intensities of phosphorylated 
p38MAPK were normalized with those of actin. The numbers shown above the columns 
represent the normalized values; (C,D) Macrophages were treated with the indicated doses 
of OA for 30 min prior to H9N2/G1 infection. The TNF-alpha mRNA levels (C) and protein 
levels in culture supernatant (D) were measured by using quantitative RT-PCR and ELISA, 
respectively; (E) PBMac were treated with DMSO or 25 nM OA for 3 h. The total RNA 
samples were then harvested and the TNF-alpha levels were quantified by using quantitative 
RT-PCR. Experiments were performed by using blood from at least five independent donors. 
* p < 0.05; ** p < 0.01. h.p.i., hour post infection; ELISA, enzyme-linked immunosorbent 
assay; DMSO, dimethylsulphoxide. 
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2.4. PP2A Is a Negative Regulator in H9N2/G1-Induced p38MAPK Activation and  
TNF-Alpha Expression 
To investigate the roles of virus-activated PP2A in the regulation of p38MAPK upon H9N2/G1 
infection, we pre-treated the PBMac with OA and examined the p38MAPK phosphorylation levels in the 
H9N2/G1-infected PBMac at 2 h.p.i. by using Western blot analysis. The phosphorylation levels of 
p38MAPK in H9N2/G1-infected PBMac were enhanced by the OA treatment in a dose-dependent 
manner (Figure 3B, lanes 3 and 4). In contrast, p38MAPK was not activated in PBMac with OA 
treatment only (Figure S3). These results show that PP2A was involved in suppressing the p38MAPK 
activation in H9N2/G1-infected cells. 
We then examined the effects of OA on H9N2/G1-induced TNF-alpha production [10]. As shown in 
Figure 3C,D, OA further increased the levels of TNF-alpha mRNA and protein in H9N2/G1-infected 
PBMac and in a dose-dependent manner. However, OA did not induce the TNF-alpha mRNA level in 
uninfected PBMac (Figure 3E). Our results revealed that PP2A played a role in damping the 
p38MAPK-mediated TNF-alpha production in PBMac with H9N2/G1 infection.  
2.5. H1N1 also Induces PP2A Activation in Primary Human Blood Macrophages 
Whether PP2A activation is specific to H9N2/G1 infection, we measured the PP2A activity in H1N1- 
and H9N2/G1-infected PBMac at 2 h.p.i. Our results show that H1N1 also induced PP2A activity and 
there was no significant difference of PP2A activity between H1N1- and H9N2/G1-infected cells 
(Figure 4A). In addition, blocking the PP2A activity by OA increased the phosphorylation of p38MAPK 
and TNF-alpha mRNA in H1N1-infected PBMac (Figure 4B,C) suggesting that PP2A activation is not 
specific to H9N2/G1 infection.  
Signaling cascades of MAPK and phosphatases play critical roles in the regulation of proinflammatory 
cytokines production during microbial infections to prevent the uncontrolled inflammatory reactions 
that lead to the deleterious effects on the host. We previously reported p38MAPK mediates, in part, the 
hyperinduction of TNF-alpha in primary human blood macrophages with H5N1/97 infection [10]. In the 
current study, we further investigate the negative regulatory mechanisms of p38MAPK-mediated 
hyperinduction of TNF-alpha in influenza virus infections. Our results show that H9N2/G1, like 
H5N1/97 virus, induced p38MAPK activation and high level of TNF-alpha production in macrophages 
when compared with the seasonal H1N1 virus. Moreover, H9N2/G1 induced the activation of PP2A but 
not MKP-1in the infected cells. With the treatment of PP2A inhibitor, the levels of p38MAPK activity 
and TNF-alpha production were enhanced suggesting PP2A plays a role in negative regulation of 
p38MAPK activation in H9N2/G1 infection. However, H9N2/G1 did not induce PP2A expression 
indicating that the activation of PP2A is not mediated by p38MAPK. On the other hand, PP2A may not 
be the targets of H9N2/G1 in the upstream of p38MAPK signaling pathways since H1N1 also induced 
PP2A activation in primary macrophages.  
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Figure 4. Involvement of PP2A in modulating the activation of p38MAPK phosphorylation 
and the TNF-alpha hyperinduction in H1N1-infected primary human blood macrophages. 
(A) Primary human monocyte-derived macrophages (PBMac) were mock-treated, infected 
with H1N1 or H9N2/G1 at a m.o.i. of 2. At 2 h.p.i., total cell lysates were harvested and 
PP2A activity was quantified by using PP2A Phosphatase Assay Kit (Millipore, Billerica, 
MA, USA); (B) PBMac were mock-treated or treated with 15 or 25 nM okadaic acid (OA) 
for 30 min prior to H1N1 infection. Upper panel: total protein lysates were harvested at  
2 h.p.i. and phosphorylated p38MAPK was detected by using Western blot analysis. Actin 
was used as a loading control. Lower panel: the band intensities in the upper panel were 
measured by Quantity One imaging software (Bio-Rad, Hercules, CA, USA). The relative 
band intensities of the phosphorylated p38MAPK compared to actin were presented;  
(C) Total RNA from H1N1-infected cell treated with OA were harvested at 3 h.p.i.; 
TNF-alpha mRNA levels were measured by TaqMan Gene Expression Assay. Experiments 
were performed by using blood from at least three independent donors. * p < 0.05. 
 
 
Despite the activation of PP2A, the levels of H9N2/G1-induced p38MAPK phosphorylation and the 
subsequent TNF-alpha production were still much higher than those in cells with H1N1 infection. This 
high level of p38MAPK phosphorylation raises a question on its roles in the virus infection. Previous 
study shows that p38MAPK facilitates influenza virus entry in human airway epithelial cells [25]. 
However, there was no significant difference in the levels of nucleoprotein in H9N2/G1-infected PBMac 
at 0, 4 and 8 h.p.i. with or without SB203580 treatment suggesting that p38MAPK does not facilitate the 
virus entry into primary human blood macrophages (Figure S1C). Whether this high level of p38MAPK 
phosphorylation contributes to other mechanisms that favor the virus replication needs to be  
further investigated.  
Int. J. Mol. Sci. 2013, 14 7337 
 
 
The mechanisms of PP2A regulated cytokine production in influenza virus infections remain 
investigated. In this study, we used okadaic acid to inhibit the catalytic activity of PP2A. Since the 
substrate specificity of PP2A is determined by the combination of regulatory subunits and conserved 
catalytic subunits [26], the target of regulatory subunits of PP2A that are involved in suppressing 
TNF-alpha production will be our future study.  
3. Experimental Section 
3.1. Reagents and Antibodies 
Specific antibodies against phosphorylated p38MAPK, ERK1/2 and JNK were purchased from Cell 
Signaling Technology (Beverly, MA, USA), while antibodies specific to MKP-1 and actin were 
purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Antibodies specific toPP2A C subunit 
were purchased from Millipore. Specific inhibitors against p38MAPK (SB203580) and PP2A (okadaic 
acid) were purchased from Merck Millipore (Billerica, MA, USA).  
3.2. Cells and Viruses 
Human monocyte-derived macrophages from healthy donors (Hong Kong Red Cross Blood 
Transfusion Service) were prepared as previously described [10,12]. In brief, blood mononuclear cells 
were separated by Ficoll–Paque centrifugation and purified by the adherence method. Monocytes were 
differentiated in RPMI 1640 (Life Technologies, Carlsbad, CA, USA) supplemented with 5% 
heat-inactivated autologous plasma. Differentiated macrophages were obtained after culturing for  
14 days. Influenza viruses including A/Quail/Hong Kong/G1/97 (H9N2/G1) and A/Hong Kong/54/98 
(H1N1) were grown in Madin–Darby canine kidney cells and were purified by pre-adsorption to and 
elution from turkey red blood cells. Virus infectivity was determined by titration on Madin–Darby 
canine kidney cells. 
3.3. Virus Infection 
Macrophages were infected with the viruses at a multiplicity of infection of two for 30 min at 37 °C. 
The supernatant containing the virus inoculum was then removed, and the cells were incubated in 
macrophage serum-free medium (Life Technologies, Carlsbad, CA, USA) supplemented with 0.6 mg/mL 
penicillin and 60 mg/mL streptomycin. The mock-treated control was incubated with the buffer under 
parallel conditions. 
3.4. Protein Extraction 
Proteins were harvested by using SDS-lysis buffer containing 1% Triton X-100, 0.5% NP-40,  
150 mM NaCl, 10 mM Tris–HCl (pH 7.4), 1 mM EDTA, 1 mM EGTA (pH 8.0), 1% SDS,  
0.2 mg/mL PMSF, 1 μg/mL aprotinin, 1 mM sodium orthovanadate, 2 μg/mL pepstatin, 2 μg/mL 
leupeptin and 10 mM sodium fluoride. 
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3.5. Quantitative Reverse Transcription-PCR Analyses 
Total RNA was extracted with TRIzol reagent (Life Technologies, Carlsbad, CA, USA) according to 
the manufacturer’s instructions. The cDNA was synthesized from total RNA with oligo (dT) primers and 
Superscript II reverse transcriptase (Life Technologies, Carlsbad, CA, USA. The levels of mRNA 
encoding TNF-alpha were assayed with TaqMan Gene Expression Assays (Life Technologies, 
Carlsbad, CA, USA). 
3.6. Quantitative Analyses of TNF-Alpha by Enzyme-Linked Immunosorbent Assays (ELISA) 
Supernatant samples of macrophage cultures were collected at the indicated time points after 
infection and irradiated with UV light before the level of TNF-alpha was measured with specific ELISA 
Kits (R&D Systems, Minneapolis, MN, USA). 
3.7. Protein Phosphatase 2A Activity Assay 
Cells were washed with pre-chilled PBS once and incubated with by phosphatase lysis buffer  
(20 mM HEPES, 10% Glycerol, 0.5% NP-40, 1 mM EGTA, 2 mM EDTA, 0.1 mM MgCl2, 20 mM 
Imidazole-HCl, 1 mM benzamidine, 10 μg/mL aprotinin, 10 μg/mL leupeptin, 1 mM PMSF, pH 7.0) on 
ice for 5 min. The cells were collected by scrapers, sonicated three times for 10 s on ice and then 
centrifuged at 2000× g for 5 min at 4 °C. The supernatant was collected and the protein concentration 
was measured by BCA kit (Thermo Scientific, Waltham, MA, USA). PP2A activity was carried out by 
malachite green-based PP2A Immunoprecipitation Phosphatase Assay Kit (Millipore, Billerica, MA, 
USA), following the manufacturer’s protocol. 
3.8. Statistical Analysis 
Data obtained from two groups with different treatments were analyzed by two-tailed, paired 
Student’s t-test (statistical significance if p < 0.05). 
4. Conclusions 
Taken together, our results show that H9N2/G1 induced a higher level of TNF-alpha production than 
that of H1N1 viruses and this hyperinduction was mediated by p38MAPK. PP2A involved the 
regulation of p38MAPK activation and TNF-alpha production in H9N2/G1 infection. However, 
H9N2/G1 did not induce the expression of PP2A indicating that the activation of PP2A is not mediated 
by p38MAPK in virus-infected PBMac. Our results may give new insights into the control of cytokine 
expression in influenza virus infection and may provide information in the development of therapeutics 
in controlling cytokine dysregulations in the disease process.  
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